Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to quantify the psychological, social, and emotional impact of comprehensive aesthetic treatment with a portfolio of the Sponsor's products by measuring the change in subject's satisfaction with facial appearance from baseline (before any treatment) to the final study visit


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04609020
Study type Interventional
Source Allergan
Contact
Status Completed
Phase Phase 4
Start date February 15, 2023
Completion date May 10, 2024

See also
  Status Clinical Trial Phase
Completed NCT01189760 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines Phase 3
Completed NCT02261493 - A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial Rhytides Phase 3
Completed NCT01224015 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines Phase 3
Completed NCT02176356 - Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study) Phase 4
Completed NCT01600729 - Reliability of the Facial Wrinkle Scale in Japanese Subjects N/A
Completed NCT01391299 - Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines N/A
Completed NCT01777620 - A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides Phase 4
Completed NCT00842062 - Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation Phase 1/Phase 2
Completed NCT01299103 - Safety and Efficacy of Single Therapy Versus Double and Triple Therapy of the Pellevé™ Wrinkle Treatment System for the Treatment of Moderate Facial Wrinkles N/A
Completed NCT01608659 - An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A